Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.57 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.57 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.55 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.55 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.55 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.55 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.54 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | RRM1 | P23921 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.47 |
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.47 |
| ▸ | NOS2 | P35228 | 1/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10615527 | 1.00 | GRIK1 (0.57) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL27608418 | 0.98 | GRIK1 (0.56) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL28032333 | 0.98 | GRIK1 (0.56) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL9362560 | 0.98 | GRIK1 (0.56) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL460141 | 0.98 | GRIK1 (0.56) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL25635471 | 0.96 | NOD1 (0.55) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL10285774 | 0.95 | NOD1 (0.52) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL10286387 | 0.95 | NOD1 (0.52) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL22777682 | 0.93 | GRIK1 (0.53) | GRIK1GRIK2GNAI3GNAO1GNAI1 | |
| SCHEMBL25227671 | 0.91 | GSR (0.52) | GRIK1GRIK2GNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3467106-B1 | PEPTIDE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2025-07-09 | — | — | EP | disclosed |
| US-10087229-B2 | Peptide compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-10-02 | — | — | US | disclosed |
| US-20160052988-A1 | PEPTIDE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-02-25 | — | — | US | disclosed |
| US-9200051-B2 | Peptide compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-12-01 | — | — | US | disclosed |
| US-20140357552-A1 | PEPTIDE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-12-04 | — | — | US | disclosed |
| EP-1748805-B1 | ABSORBABLE BIOCOMPATIBLE COATINGS | BIOINTERACTIONS LTD (GB) | 2009-07-29 | — | — | EP | disclosed |
| CN-1956742-A | Absorbable biocompatible materials | BIOINTERACTIONS LTD (GB) | 2007-05-02 | — | — | CN | disclosed |
| EP-1748805-A1 | ABSORBABLE BIOCOMPATIBLE MATERIALS | Biointeractions Ltd. (GB) | 2007-02-07 | — | — | EP | disclosed |
| US-20060134166-A1 | Absorbable biocompatible materials | BIOINTERACTIONS LTD. (GB) | 2006-06-22 | — | — | US | disclosed |
| WO-2005115492-A1 | ABSORBABLE BIOCOMPATIBLE MATERIALS | BIOINTERACTIONS LTD (GB) | 2005-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160052988-A1 | PEPTIDE COMPOUND | GIPR, GLP1R, VIP | GRIK1 1026/4885GRIK2 2186/4885GNAI3 590/4885 |
| US-20060134166-A1 | Absorbable biocompatible materials | ADM2, HDGF, SLC7A1 | GRIK1 3278/4885GRIK2 3220/4885GNAI3 3841/4885 |
| US-20140357552-A1 | PEPTIDE COMPOUND | GLP1R, GIPR, VIP | GRIK1 795/4885GRIK2 1793/4885GNAI3 459/4885 |
| US-10087229-B2 | Peptide compound | GLP1R, GIPR, VIP | GRIK1 953/4885GRIK2 1939/4885GNAI3 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.